NPM-ALK phosphorylates WASp Y102 and contributes to oncogenesis of anaplastic large cell lymphoma

被引:0
|
作者
C A Murga-Zamalloa
V Mendoza-Reinoso
A A Sahasrabuddhe
D Rolland
S R Hwang
S R P McDonnell
A P Sciallis
R A Wilcox
V Bashur
K Elenitoba-Johnson
M S Lim
机构
[1] University of Michigan,Department of Pathology
[2] University of Pennsylvania,Department of Pathology and Laboratory Medicine
[3] University of Michigan,Department of Internal Medicine
来源
Oncogene | 2017年 / 36卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Mechanisms by which NPM-ALK signaling regulates cell migration, invasion and contributes to the oncogenesis of anaplastic large cell lymphoma (ALCL) are not completely understood. In an attempt to identify novel actin signaling pathways regulated by NPM-ALK, a comprehensive phosphoproteome analysis of ALCL cell lines was performed in the presence or absence of NPM-ALK activity. Numerous phosphoproteins involved in actin dynamics including Wiskott–Aldrich syndrome protein (WASp) were regulated by NPM-ALK. Network analysis revealed that WASp is a central component of the NPM-ALK-dependent actin signaling pathway. Here we show that NPM-ALK phosphorylates WASp at its known activation site (Y290) as well as at a novel residue (Y102). Phosphorylation of WASp at Y102 negatively regulates its interaction with Wiskott–Aldrich interacting protein and decreases its protein stability. Phosphorylation of WASp at Y102 enhances anchorage-independent growth and tumor growth in an in vivo xenograft model and enhances invasive properties of ALCL. We show that knock-down of WASp or expression of Y102F mutant of WASp decreases colony formation and in vivo tumor growth. Our results show that WASp is a novel substrate of ALK and has a critical role in regulating invasiveness and oncogenesis of ALCL.
引用
收藏
页码:2085 / 2094
页数:9
相关论文
共 50 条
  • [11] Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas
    HG Drexler
    SM Gignac
    R von Wasielewski
    M Werner
    WG Dirks
    Leukemia, 2000, 14 : 1533 - 1559
  • [12] Analysis of nucleophosmin-anaplastic lymphoma kinase (NPM-ALK)-reactive CD8+ T cell responses in children with NPM-ALK+ anaplastic large cell lymphoma
    Singh, V. K.
    Werner, S.
    Hackstein, H.
    Lennerz, V.
    Reiter, A.
    Woelfel, T.
    Damm-Welk, C.
    Woessmann, W.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2016, 186 (01): : 96 - 105
  • [13] MKK4 and MKK7 Interact with NPM-ALK and Contribute to Tumor Cell Proliferation and Survival in NPM-ALK plus Anaplastic Large Cell Lymphoma
    Rassidakis, G.
    Georgoulis, P.
    Atsaves, V.
    Tsioli, P.
    Drakos, E.
    Medeiros, L. J.
    Panayiotidis, P.
    Patsouris, E.
    MODERN PATHOLOGY, 2010, 23 : 318A - 318A
  • [14] NPM-ALK expression levels identify two distinct subtypes of paediatric anaplastic large cell lymphoma
    E Pomari
    G Basso
    S Bresolin
    M Pillon
    E Carraro
    E S d'Amore
    G Viola
    C Frasson
    K Basso
    P Bonvini
    L Mussolin
    Leukemia, 2017, 31 : 498 - 501
  • [15] Prognostic significance of NPM-ALK fusion transcript overexpression in ALK-positive anaplastic large-cell lymphoma
    Li, Chunmei
    Takino, Hisashi
    Eimoto, Tadaaki
    Ishida, Takashi
    Inagaki, Atsushi
    Ueda, Ryuzo
    Suzuki, Ritsuro
    Yoshino, Tadashi
    Nakagawa, Atsuko
    Nakamura, Shigeo
    Inagaki, Hiroshi
    MODERN PATHOLOGY, 2007, 20 (06) : 648 - 655
  • [16] NPM-ALK Is a Key Regulator of the Oncoprotein FOXM1 in ALK-Positive Anaplastic Large Cell Lymphoma
    Haque, Moinul
    Li, Jing
    Huang, Yung-Hsing
    Almowaled, Meaad
    Barger, Carter J.
    Karpf, Adam R.
    Wang, Peng
    Chen, Will
    Turner, Suzanne D.
    Lai, Raymond
    CANCERS, 2019, 11 (08)
  • [17] NPM/ALK binds and phosphorylates the RNA/DNA binding protein PSF in anaplastic large cell lymphoma
    Galietta, A.
    Gunby, R. H.
    Redaelli, S.
    Bachi, A.
    Piazza, R. G.
    Villa, A.
    Pogliani, E. M.
    Gambacorti-Passerini, C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 48 - 49
  • [18] NPM-ALK expression levels identify two distinct subtypes of paediatric anaplastic large cell lymphoma
    Pomari, E.
    Basso, G.
    Bresolin, S.
    Pillon, M.
    Carraro, E.
    d'Amore, E. S.
    Viola, G.
    Frasson, C.
    Basso, K.
    Bonvini, P.
    Mussolin, L.
    LEUKEMIA, 2017, 31 (02) : 498 - 501
  • [19] NPM-ALK expression levels are associated to different miRNA profiles in paediatric anaplastic large cell lymphoma
    Garbin, Anna
    Lovisa, Federica
    Basso, Katia
    Holmes, Antony B.
    Carraro, Elisa
    Pizzi, Marco
    Garaventa, Alberto
    Tondo, Annalisa
    Mura, Rossella
    Buffardi, Salvatore
    Basso, Giuseppe
    D'Amore, Emanuele S. G.
    Pillon, Marta
    Mussolin, Lara
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 182 : 42 - 42
  • [20] Variant NPM-ALK chimeric product in the anaplastic large cell lyphoma (ALCL).
    Zielenska, M
    Sirkin, WL
    Fabricius, N
    Zielenski, J
    AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (04) : A332 - A332